Arsenic Primes Human Bone Marrow CD34+ Cells for Erythroid Differentiation
Arsenic trioxide exhibits therapeutic effects on certain blood malignancies, at least partly by modulating cell differentiation. Previous in vitro studies in human hematopoietic progenitor cells have suggested that arsenic may inhibit erythroid differentiation. However, these effects were all observ...
Main Authors: | Yuanyuan Zhang, Shasha Wang, Chunyan Chen, Xiao Wu, Qunye Zhang, Fan Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Bioinorganic Chemistry and Applications |
Online Access: | http://dx.doi.org/10.1155/2015/751013 |
Similar Items
-
Human Cord Blood and Bone Marrow CD34+ Cells Generate Macrophages That Support Erythroid Islands.
by: Eyayu Belay, et al.
Published: (2017-01-01) -
Immunoexpression of CD34, CD117, and p53 in Hypocellular Bone Marrow Disorders
by: Pooja Sharma, et al.
Published: (2021-08-01) -
The Effect of Mesenchymal Stem Cell-Derived Microvesicles on Erythroid Differentiation of Umbilical Cord Blood-Derived CD34+ Cells
by: Davod Pashoutan Sarvar, et al.
Published: (2018-06-01) -
Effect of platelet-activating factor on the growth of human erythroid and
myeloid CD34+ progenitors
by: F. Dupuis, et al.
Published: (1998-01-01) -
Evaluation of hematopoietic cells and myeloid/erythroid ratio in the bone marrow of the pheasant (Phasianus colchicus)
by: Mina Tadjalli, et al.
Published: (2013-06-01)